Stock 2126 JW (CAYMAN) THERAPEUTICS CO. LTD
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart JW (Cayman) Therapeutics Co. Ltd

Equities

2126

KYG5210T1040

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:07 2024-07-05 am EDT 		5-day change 1st Jan Change
1.94 HKD +2.11% Intraday chart for JW (Cayman) Therapeutics Co. Ltd -1.02% -14.16%
May. 30 JW (Cayman) Therapeutics Presents Trial Data from SLE Drug at Rheumatology Congress MT
May. 30 JW Therapeutics Co. Ltd Announces Research and Development Update Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China At the EURAL 2024 Congress CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
JW (CAYMAN) THERAPEUTICS CO. LTD
Bio Therapeutic Drugs
+2.11%-1.02%-14.16%-21.77% - 100M
Bearish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. 2126 Stock
  4. Charts JW (Cayman) Therapeutics Co. Ltd
  5. Comparison Chart